Dexibuprofen/Levocetirizine dihydrochloride

右布洛芬/盐酸左西替利嗪

Report date: 2025/03/31 10:39:09

Base Information

Drug NameDexibuprofen/Levocetirizine dihydrochloride
Drug Alias Name复方右旋布洛芬缓释双层片
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsHistamine H1 receptor antagonists
TargetsCyclooxygenasesHistamine H1 receptor
Therapy Area/IndicationsSneezingHeadacheFever +[10
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSneezingHeadacheFever +[10
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A